| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TTC3_0015500 | Exon-Exon | chr21:38494117-38525577 | chr21:37121817-37153277 | 1840 nt | 0.3810 |
| hsa_TTC3_0014700 | Exon-Exon | chr21:38494117-38529208 | chr21:37121817-37156906 | 2092 nt | 0.3815 |
| hsa_TTC3_0014800 | Exon-Exon | chr21:38494117-38545046 | chr21:37121817-37172744 | 250 nt | 0.3200 |
| hsa_TTC3_0015700 | Exon-Exon | chr21:38495283-38505066 | chr21:37122983-37132766 | 380 nt | 0.3895 |
| hsa_TTC3_0016000 | Exon-Exon | chr21:38495283-38507814 | chr21:37122983-37135514 | 135 nt | 0.4148 |
| hsa_TTC3_0015800 | Exon-Exon | chr21:38495283-38511014 | chr21:37122983-37138714 | 596 nt | 0.4027 |
| hsa_TTC3_0015900 | Exon-Exon | chr21:38495283-38512973 | chr21:37122983-37140673 | 709 nt | 0.4006 |
| hsa_TTC3_0016400 | Exon-Exon | chr21:38496919-38501363 | chr21:37124619-37129063 | 249 nt | 0.3936 |
| hsa_TTC3_0016700 | Exon-Exon | chr21:38496919-38512973 | chr21:37124619-37140673 | 124 nt | 0.3790 |
| hsa_TTC3_0016500 | Exon-Exon | chr21:38496919-38516945 | chr21:37124619-37144645 | 784 nt | 0.4005 |
A study in humans demonstrated that the circTTC3 shows a significant decrease in the peripheral blood of Alzheimer's disease patients, suggesting its potential to distinguish this condition from other dementias [Misir et al. DOI:10.1038/s41418-022-00948-7]. In mice and rats, circTTC3 was markedly upregulated in ischemic myocardium post-myocardial infarction and counteracted hypoxia-induced ATP depletion and apoptotic death in cardiomyocytes via the miR-15b/Arl2 axis [Tian et al. DOI:10.3390/molecules26041155]. It also alleviated hypoxic injury in HaCaT cells via miR-449a/NF-κB and PI3K/AKT pathways [Huang et al. DOI:10.3390/cells11091381].